153 related articles for article (PubMed ID: 23412358)
21. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks.
Menendez D; Shatz M; Azzam K; Garantziotis S; Fessler MB; Resnick MA
PLoS Genet; 2011 Mar; 7(3):e1001360. PubMed ID: 21483755
[TBL] [Abstract][Full Text] [Related]
22. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
23. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
[TBL] [Abstract][Full Text] [Related]
24. Borealin is repressed in response to p53/Rb signaling.
Date DA; Jacob CJ; Bekier ME; Stiff AC; Jackson MW; Taylor WR
Cell Biol Int; 2007 Dec; 31(12):1470-81. PubMed ID: 17716930
[TBL] [Abstract][Full Text] [Related]
25. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.
Osifchin NE; Jiang D; Ohtani-Fujita N; Fujita T; Carroza M; Kim SJ; Sakai T; Robbins PD
J Biol Chem; 1994 Mar; 269(9):6383-9. PubMed ID: 8119988
[TBL] [Abstract][Full Text] [Related]
26. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
27. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.
Santhanam U; Ray A; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7605-9. PubMed ID: 1652755
[TBL] [Abstract][Full Text] [Related]
28. Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence.
Helmbold H; Kömm N; Deppert W; Bohn W
Oncogene; 2009 Oct; 28(39):3456-67. PubMed ID: 19648966
[TBL] [Abstract][Full Text] [Related]
29. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
[TBL] [Abstract][Full Text] [Related]
30. The transcriptional activity of HERV-I LTR is negatively regulated by its cis-elements and wild type p53 tumor suppressor protein.
Chang NT; Yang WK; Huang HC; Yeh KW; Wu CW
J Biomed Sci; 2007 Mar; 14(2):211-22. PubMed ID: 17151828
[TBL] [Abstract][Full Text] [Related]
31. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.
Thornborrow EC; Manfredi JJ
J Biol Chem; 2001 May; 276(19):15598-608. PubMed ID: 11278953
[TBL] [Abstract][Full Text] [Related]
32. Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53.
Wang T; Zeng J; Lowe CB; Sellers RG; Salama SR; Yang M; Burgess SM; Brachmann RK; Haussler D
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18613-8. PubMed ID: 18003932
[TBL] [Abstract][Full Text] [Related]
33. The bidirectional p53-Wrap53β promoter is controlled by common cis- and trans-regulatory elements.
Polson A; Reisman D
Gene; 2014 Mar; 538(1):138-49. PubMed ID: 24418698
[TBL] [Abstract][Full Text] [Related]
34. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.
Rossi M; Demidov ON; Anderson CW; Appella E; Mazur SJ
Nucleic Acids Res; 2008 Dec; 36(22):7168-80. PubMed ID: 19015127
[TBL] [Abstract][Full Text] [Related]
35. The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms.
Porubiaková O; Bohálová N; Inga A; Vadovičová N; Coufal J; Fojta M; Brázda V
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878115
[TBL] [Abstract][Full Text] [Related]
36. Redefining the p53 response element.
Wang B; Xiao Z; Ren EC
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14373-8. PubMed ID: 19597154
[TBL] [Abstract][Full Text] [Related]
37. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
[TBL] [Abstract][Full Text] [Related]
38. Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53.
Zhu Z; Wei J; Shi Z; Yang Y; Shao D; Li B; Wang X; Ma Z
Biochem Biophys Res Commun; 2013 Jun; 436(2):204-11. PubMed ID: 23727578
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
Derbyshire DJ; Basu BP; Serpell LC; Joo WS; Date T; Iwabuchi K; Doherty AJ
EMBO J; 2002 Jul; 21(14):3863-72. PubMed ID: 12110597
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of Rb expression by the p53 gene product.
Shiio Y; Yamamoto T; Yamaguchi N
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5206-10. PubMed ID: 1608930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
